CLINICCARDS: Voxel-Based AI for 3D Dental Diagnosticsbroad
CLINICCARDS · Horizon Europe grant · 2026-07-01–2028-06-30
EC contribution
Total cost
Beneficiaries
About the data
Source: CORDIS (official EU open data), Horizon Europe. Framework HORIZON · call HORIZON-EIC-2025-UKRAINIANTECH-01 · scheme HORIZON-EIC · topic HORIZON-EIC-2025-UKRAINIANTECH-01. CORDIS record →
Objective
Cliniccards AI: Deep Tech Revolution in 3D Dental DiagnosticsRadiology accounts for 82% of all diagnostic errors in medicine, with practitioners missing up to 44% of pathologies due to fatigue and physiological limitations. Manual analysis of a single 3D scan (CBCT) takes 15–20 minutes, creating a critical bottleneck amidst a global staff shortage. Furthermore, the current market is compromised by non-GDPR compliant solutions with Russian origins, creating unacceptable data security risks for EU clinics.Cliniccards AI is the first fully GDPR-compliant ""Clean AI"" cloud platform for automated 3D segmentation and diagnostics. Unlike competitors relying on 2D projections, we utilize a True 3D Voxel-based approach (proprietary 3D CNN/U-Net architectures) to analyze volumetric data. The solution integrates seamlessly into the Cliniccards ERP ecosystem, already used by 4,700+ clinics, ensuring instant market access.Key Innovations:1. Data Moat: We possess the largest verified private dataset in Eastern Europe (240,000 CT scans), creating an uncopyable advantage for training Deep Learning models.2. Technological Gap: We solve the ""blind spots"" of existing AI by implementing Metal Artifact Reduction (MAR) and full segmentation of nerves and sinuses directly in voxel space.3. Digital Sovereignty: We provide a secure European alternative, ensuring data never leaves safe jurisdictions.Measurable Objectives (TRL 4 → TRL 7) Over 24 months, we aim to achieve:- Diagnostic Excellence: Sensitivity >97.3% for pathologies and >95% segmentation accuracy (IoU) for critical anatomy.- Efficiency: Reducing analysis time from 20 minutes to 2–5 seconds (150x faster).- Commercial Impact: Validating a >20% increase in Case Acceptance Rates via pilot testing and securing MDR Class IIa readiness.Action Plan The project involves finalizing R&D (specifically for artifact reduction), conducting a 3-phase ""Living Lab"" clinical trial in 50 clinics, and filing 4 patent applications""
Beneficiaries (1)
| Organisation | Country | Role | EC contribution | SME |
|---|---|---|---|---|
| LIMITED LIABILITY COMPANY ""CLINICCARDS"""" | UA | coordinator | €499,362 | Yes |
Get the EU Defence Funding Calendar — free
The full calendar of open EU defence and dual-use funding calls, sorted by deadline, updated nightly. Delivered with DFM Analysis, our weekly briefing on who is funding what in European defence.
Or browse all open defence & dual-use calls on the funding calendar →
Defence Finance Monitor is an analytical and informational product. Grant data is official CORDIS; the paid Annual Professional subscription is handled on DFM Analysis.